WO1995005209A1 - Treatment chamber catheter - Google Patents

Treatment chamber catheter Download PDF

Info

Publication number
WO1995005209A1
WO1995005209A1 PCT/US1994/009262 US9409262W WO9505209A1 WO 1995005209 A1 WO1995005209 A1 WO 1995005209A1 US 9409262 W US9409262 W US 9409262W WO 9505209 A1 WO9505209 A1 WO 9505209A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
treatment chamber
lumen
catheter
member
proximal
Prior art date
Application number
PCT/US1994/009262
Other languages
French (fr)
Inventor
John B. Simpson
Scott C. Anderson
Original Assignee
Technology Development Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/013Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stending
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1011Multiple balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02Dilators made of swellable material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22031Gripping instruments, e.g. forceps, for removing or smashing calculi
    • A61B17/22032Gripping instruments, e.g. forceps, for removing or smashing calculi having inflatable gripping elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/225Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22082Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
    • A61B2017/22084Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance stone- or thrombus-dissolving
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2002/018Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0006Rounded shapes, e.g. with rounded corners circular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0065Three-dimensional shapes toroidal, e.g. ring-shaped, doughnut-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0067Three-dimensional shapes conical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M2025/0183Rapid exchange or monorail catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1052Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1068Balloon catheters with special features or adapted for special applications having means for varying the length or diameter of the deployed balloon, this variations could be caused by excess pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1097Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation only while the balloon is in an inflated state, e.g. temporary by-pass within balloon

Abstract

A multiple lumen catheter device (10) for use in removing friable material from a vein graft or other treatment site as a preliminary step to conventional atherectomy. The device has a pair of spaced apart balloons (24, 26) attached near the distal end (16) and includes lumina (18, 20) for control of balloon expansion. The region between the balloons (24, 26) defines a treatment chamber (34) from which loosened material does not escape into the blood stream. Access to the treatment chamber (34) is through an aspiration and access lumen (20) having an inside diameter large enough to permit insertion of a variety of catheter devices for removal of burden or examination of the site. Infusion of a flushing fluid or medication is provided through the inserted catheter device or through a separate lumen. Aspiration of loosened material and excess fluid takes place through the aspiration and treatment chamber access lumen (20). One embodiment includes perfusion (36, 38) around the treatment chamber (34) to prevent ischemia.

Description

TREATMENT CHAMBER CATHETER

Technical Field:

This invention relates to catheters and more particularly to catheters which include multiple lumina and which have multiple balloons for defining a treatment chamber.

Background Art:

Blood vessels at certain critical parts of the human circulatory system can and often do become burdened with deposits, coatings, occlusions, etc., which can reduce the vessel's blood carrying capacity. In some patients, this reduced capacity can cause serious and permanent injury. As a result, when significant burden is found to exist, some form of medical intervention is often indicated.

A number of intervention techniques have been developed over the years. These techniques permit the removal or reduction of the burden so that an increased and healthier blood flow can result. When a normal flow cannot be restored by these methods, the burdened portions of the vessel are sometimes bypassed using a vessel taken from elsewhere in the body. When the original blood vessel is a coronary artery, the bypass procedure is referred to as a coronary artery bypass graft.

The bypass graft itself may in time become burdened, as was the original vessel, therefore requiring further intervention. One type of burden that is of particular concern in treatment of a bypass arises when a vein has been used to make the bypass graft. Venous grafts are particularly susceptible to deposits of a friable material which is easily loosened during an intervention. The friable material is of a crumbly nature and pieces are easily dislodged from the inside of the bypass graft. Often a treatment site will include a high proportion of such friable material surrounding other types of burden. Under these circumstances, attempts to remove the other burden often result in much of the friable material breaking loose and entering the blood stream. This loosened biological debris can block the artery and cause myocardial infarction.

The intervention techniques referred to above include use of known devices such as balloon angioplasty, rotational atherectomy, the transluminal extraction catheter, stents, and the directional coronary atherectomy. Each of these techniques, and others, are favored by practitioners in the treatment of diseased saphenous vein grafts and other vessels. Yet, each of these techniques exposes a patient to some greater or lesser degree of risk of embolism. Unfortunately, this risk is present under the most carefully conducted intervention because the friable material can be so easily dislodged. This can happen even while merely positioning or repositioning a catheter device at a burdened region of the vessel.

What is needed is a device which can be used in conjunction with other treatment devices and will allow a successful removal of the friable material from the treatment region without increasing a risk of formation of emboli.

Disclosure of Invention:

It is an object of the present invention to provide a catheter device which will be used to stabilize a treatment site. A treatment site is "stabilized" by removing friable material from the vessel walls. and thus reducing the risk of embolization.

It is a further object of this invention to create a treatment chamber which is sealed off from the normal blood flow at a treatment site.

It is a further object of this invention to permit removal of the friable material at the treatment site and to do so within the sealed treatment chamber in order that loose material does not escape into the blood stream.

It is a further object of this invention to provide infusion and aspiration of the sealed treatment chamber to aid in a safe removal of loosened material.

It is a further object of this invention to allow the introduction of medications to the treatment site by way of infusion, and to confine the medications to the sealed treatment chamber. It is a further object of this invention to permit use of the sealed and flushed treatment chamber by other catheter type treatment devices used to remove any other burden, such as discrete lesions, once the site is stabilized. Finally, it is an object of the present invention to reduce ischemic stress resulting from the sealing of a vessel by use of perfusion around the sealed treatment chamber. This object will allow the treatment chamber to remain in place for a prolonged intervention interval.

In accordance with the above objects and those that will be mentioned and will become apparent below, the treatment chamber catheter device of the present invention comprises a multiple lumen catheter for insertion into a biological conduit, the catheter comprising: a catheter member including multiple lumina and having proximal and distal ends; an expandable sealing member for sealing off fluid flow between the proximal and distal ends within the biological conduit defining a treatment chamber between the proximal and distal ends, the catheter member having a lumen for accessing the treatment chamber and for removing fluid and biological debris from the treatment chamber, whereby, an accessible, sealed treatment chamber is provided which retains loosened biological material for removal through the second lumen. In a preferred embodiment of the present invention, the expandable sealing member includes first and second expandable members, one expandable member being located distal to, the other located proximal to a treatment site. A treatment chamber being defined as the region within the vessel and located between the expandable sealing members. In another preferred embodiment, the catheter member includes a perfusion lumen having openings located proximal to and distal to the treatment chamber. The perfusion lumen and openings allow blood to bypass the treatment chamber within the treated vessel, thus controlling ischemic stress.

In another preferred embodiment, the catheter member includes an independent infusion lumen having an opening into the treatment chamber, whereby a saline or flushing solution and the like can be introduced through the infusion lumen into the treatment chamber. The embodiment also includes a separate aspiration lumen having an opening into the treatment chamber, whereby fluids and biological debris may be removed through the aspiration lumen by suction. The treatment chamber catheter summarized above provides a fluid sealed treatment region to which access is gained via a catheter lumen. A variety of catheter-type treatment devices can be inserted into and removed from the treatment chamber. The treatment chamber, once established, can remain in place while such devices are introduced into the treatment chamber to treat or monitor the intervention. This can be accomplished without increasing the risk of additional trauma to the vessel, since the devices can be inserted through the larger access lumen.

Typical of the devices which can be used with the treatment chamber catheter are the angioscope, the ultrasonic transducer for imaging, and a variety of devices used to excise tissue.

Finally, one preferred embodiment replaces the expandable sealing members with a fine meshed screen located distal to the treatment site. The use of this screen allows the natural flow of the vessel's biological fluids without a need for a separate perfusion lumen, and prevents loosened biological material from entering the natural fluid flow.

It is an advantage of this invention to provide a treatment chamber catheter device which can be used in conjunction with a variety of other catheter type devices to stabilize a treatment site in saphenous vein graft disease. It is an advantage of this invention to provide a treatment chamber catheter device which can be used to apply and confine a medication to a specific treatment site. It is an advantage of this invention to provide a treatment chamber catheter device which can be used in conjunction with a variety of other catheter type treatment devices to provide a sealed treatment chamber during an intervention and diagnosis. It is an advantage of this invention to provide an isolated treatment chamber for accommodating a variety of devices for vascular intervention and diagnosis.

It is a further advantage of this invention to enable the repeated insertion and removal of such devices while minimizing trauma to the biological conduit. It is a further advantage of this invention to prevent loosened material from entering the biological conduit's natural fluid flow.

Finally, it is an advantage of this invention to provide a perfusion bypass around the isolated treatment chamber for the natural fluid flow, thus reducing ischemic stress.

Brief Description of Drawings:

For a further understanding of the objects and advantages of the present invention, reference should be had to the following detailed description, taken in conjunction with the accompanying drawing, in which like parts are given like reference numerals and wherein:

Fig. 1 is a partial perspective view of the treatment chamber catheter in accordance with the present invention.

Figs. 2 through 6 are cross-sectional views taken through corresponding lines of Fig. 1. Figs. 7 through 10 are cross-sectional views corresponding to Figs. 2 through 5, respectively, and illustrate additional catheter lumen.

Fig. 11 is a partial perspective view of the perfusion lumen showing an in¬ line forced perfusion pump.

Fig. 12 is a cross-sectional view corresponding to Figs. 2 and 7 showing dual perfusion lumen.

Fig. 13 is a partial side view of the treatment chamber catheter having the expandable sealing members replaced by a fine-meshed screen.

Fig. 14 is a partial perspective view of the treatment chamber catheter of Fig. 13 illustrating the screen in an extended position.

Fig. 15 is a partial perspective view of the treatment chamber catheter of Fig. 13 showing the screen in a retracted position.

Best Mode for Carrying Out the Invention:

Figure 1

The invention will now be described with respect to Fig. 1 , which illustrates the treatment chamber catheter shown generally by the numeral 10 in accordance with the present invention.

The words "proximal" and "distal" as used herein have the following meaning, the proximal end of the catheter device is the end associated with the operator of the device. The distal end is the end furthest from the operator. The phrases "blood vessel" and "biological conduit" are used interchangeably herein. Though typically the treatment chamber catheter 10 will be employed within a blood vessel, it should not be so limited. In general it can be used within any biological vessel or conduit of a body. Similarly the phrases "blood" and "biological fluid" are used interchangeably. The treatment chamber catheter 10 includes an elongated multiple lumen catheter member 12 having a proximal end shown generally by the numeral 14 and a distal end 16. The catheter member 12 has a first lumen 18 extending and terminating at the distal end 16 in an atraumatic lumen termination 32. A second lumen 20 of the catheter member 12 terminates in an opening 22. The catheter member 12 has two expandable sealing members 24, 26 which are attached to an outer surface 28 of the catheter member 12. A first expandable sealing member 24 is located proximally to the opening 22 of the second lumen 20. A second expandable sealing member 26 is located distally to the first expandable sealing member 24 and is attached to the outer surface 28.

A treatment chamber shown generally by the numeral 34 is created in the region located between the first and second expandable sealing members 24, 26. The treatment chamber 34 is defined by the opening 22 of the second lumen 20 into the region located between the first and second expandable sealing members 24, 26. Access to the treatment chamber 34 is provided via the second lumen 20.

The distally extending first lumen 18 is used to bypass the biological fluid around the treatment chamber 34. The first lumen 18 has proximal perfusion openings 36 located proximally to the first expandable sealing member 24 and has distal perfusion openings 38 located distally to the second expandable sealing member 26 along the distally extending first lumen 18.

A guide wire 30 enters the distally extending first lumen 18 proximal to the first expandable sealing member 24. The guide wire 30 is carried within the distally extending first lumen 18 to the distal end 16. The guide wire 30 extends beyond the atraumatic lumen termination 32 for guiding the catheter 10 within a blood vessel or other biological conduit (not shown).

Typical Use

In a typical use of the present invention, a guiding catheter (not shown) is inserted and left in position during the remainder of the intervention. The use of a guiding catheter will be understood by those skilled in the art as useful to reduce trauma resulting from repeated insertions and removals of catheter devices, and to reduce the overall duration of the intervention. Typically, in the case of coronary vessels, the guiding catheter will extend distally from a point of insertion at the groin into the aorta. Once the guiding catheter is in place, the treatment chamber catheter 10 is inserted through the guiding catheter, and is positioned, with the aid of fluoroscopy, extending through the aorta to a treatment site within an arterial vessel of the heart, or a coronary artery bypass graft.

When the treatment chamber catheter 10 has been positioned, the expandable sealing members 24, 26 are inflated to form a fluid seal with the walls of the blood vessel or bypass graft. The seal thus created prevents the natural flow of arterial blood through the treatment chamber 34. Perfusion allows the blood to bypass the treatment chamber 34 by passing the blood through the perfusion openings 36, 38 and the interconnecting distally extending first lumen 18. In a preferred embodiment, the effective diameter of the distally extending first lumen 18 and of the perfusion openings 36, 38 allow the blood to flow at a rate of approximately 40 cc per minute.

A device for vascular intervention, for example a catheter-type cutting or grinding instrument (not shown), can now be inserted into the second lumen 20 which opens into the treatment chamber 34. The cutting or grinding tip of the inserted device is moved into the treatment chamber 34. Tissue is accessible to the tip of the inserted device because the treatment chamber 34 is open to the walls of the vessel.

The inserted instrument is operated to loosen the friable material from the walls of the arterial vessel at the treatment site. Excised fragments of the removed material are trapped within the treatment chamber 34. The expandable sealing members 24, 26 prevent the fragments from being carried away by the vessel's natural blood flow.

In a preferred embodiment, the treatment chamber 34 is constantly flushed by infusion through a lumen of the inserted instrument and aspiration through the second lumen 20. Loosened friable material is withdrawn from the treatment chamber 34 as the flushing fluid is withdrawn by aspiration.

Once the friable material has been removed from the vessel walls at the treatment site, the inserted instrument is withdrawn with minimum trauma to the surrounding tissue. Fragments which are too large to be removed in this manner can be reduced in size by using the cutting or grinding instrument before it has been withdrawn. Vacuum is applied via the proximal end of lumen

20 around any inserted instrument.

Once the treatment site has been stabilized by removal of most of the friable material, the treatment chamber catheter can be removed, allowing the use of standard interventions, such as directional coronary atherectomy, angioplasty, and the like. Alternatively, the treatment chamber catheter can be left in place and another catheter device can be inserted into the treatment chamber for performing a primary intervention.

The Treatment Chamber The treatment chamber 34 is created at the termination of the outer wall

42 (Fig. 2) in the opening 22 of the second lumen 20 and is located between the two expandable sealing members 24 and 26. In a preferred embodiment, the treatment chamber 34 has an effective length of approximately 2 - 4 cm. This effective length is defined as the distance between the two expandable sealing members.

Figures 2 through 6

The multiple lumen catheter member 12 is shown in cross-section in Figs. 2 through 6. Each of these cross-sections is taken in the direction of the arrows at a corresponding line, 2-2 through 6-6, of Fig. 1.

Fig. 2 shows a cross-section taken through the multiple lumen catheter member 12 in the direction of the arrows at line 2-2 of Fig. 1. The multiple lumen catheter member 12 includes the distally extending first lumen 18 and the second lumen 20. The distally extending first lumen 18 has a barrier 46 extending from the proximal end 14 and terminating distally of the distal expandable sealing member 26. The barrier 46 creates an inflation lumen 40 within the distally extending first lumen 18. The distally extending first lumen 18 has an outer wall 44 which separates the lumen 18 from the second lumen 20. The second lumen 20 has an outer wall 42. The guide wire 30 is shown outside the multiple lumen catheter member 12 and adjacent the outer wall 42. The guide wire 30 will typically have a diameter of either 0.014 or 0.018 inch.

In a preferred embodiment, an outer diameter of the multiple lumen catheter member 12 will be approximately 0.105 inch, and an effective working diameter of the second lumen 20 will be approximately 0.080 inch. This working diameter will allow the insertion into the second lumen 20 of a catheter-type instrument having an outer diameter of approximately 0.060 inch. Methods and apparatus for forming multiple lumen catheters are well known. Typically an extrusion process is used to obtain complex concentric structures such as those used in the present invention. Catheters of very small diameter can be produced by such a process. Fig. 3 is a cross-sectional view taken through the multiple lumen catheter member 12 in the direction of the arrows at line 3-3 of Fig. 1. The proximal expandable sealing member 24 is shown surrounding the multiple lumen catheter member 12. The identification numerals used in Fig. 3 for the details of the multiple lumen catheter member 12 are identical to those shown in Fig. 2. The guide wire 30 is shown inside the distally extending first lumen 18, having passed through an outer wall of the treatment chamber catheter 10, as illustrated in Fig. 1. An opening 48 connects the inflation lumen 40 and the interior of the proximal expandable sealing member 24.

The proximal expandable sealing member 24 can be inflated by an infusion of a liquid at the proximal end 14 into the inflation lumen 40. The liquid will pass along the inflation lumen 40, moving distally, and then urged by the distal termination of the inflation lumen 40 will pass through the opening 48 and into the interior of the proximal expandable sealing member 24. In this manner, the expandable sealing member 24 will become inflated. Fig. 4 is a cross- sectional view taken through the distally extending first lumen 18 in the direction of the arrows at line 4-4 of the treatment chamber catheter 10 of Fig. 1. The identification numerals are the same as those used in Figs. 2 and 3, and refer to the same elements. The guide wire 30 is shown inside the distally extending first lumen 18. Fig. 5 is a cross-sectional view taken through the distal expandable sealing member 26 and the distally extending first lumen 18 in the direction of the arrows at line 5-5 of the treatment chamber catheter 10 of Fig. 1. An opening 50 is shown connecting the inflation lumen 40 with the interior of the interior of the distal expandable sealing member 26. During inflation, fluid being forced into lumen 40 at its proximal end passes through the opening 50 and into the expandable member 26 resulting in an increase in the diameter of the expandable member. As a result, a biological fluid seal is created between the expandable sealing members 24, 26 and the wall of a biological conduit (not shown). Deflation of both expandable sealing members 24, 26 results when the fluid introduced into lumen 40 is withdrawn. In preferred embodiments, the expandable sealing members 24, 26 are made of either a compliant or of a non-compliant material. The expandable sealing members 24, 26 are attached to the outer surface of the treatment chamber catheter 10 by any of a variety of methods including use of a heat seal, use of adhesive, or by a combination of adhesive and wrapping. An outer diameter of the expandable sealing members 24, 26 varies in a range from 3 mm to about 6 mm and has a typical value of approximately 5 mm.

Reference to Figs. 1 , 3 and 5 shows that the two expandable members 24, 26 do not share a common axis. The proximal expandable sealing member 24 has a common axis with the proximal portion of the multiple lumen catheter member 12. The distal expandable sealing member 26 on the other hand has a common axis with the distally extending first lumen 18. The resulting offset does not prevent formation of an adequate biological fluid seal between the expandable members 24, 26 and the biological conduit. Alternatively, one or both expandable sealing members can be formed to maintain the lumen generally centered within the biological conduit.

Fig. 6 is a cross-sectional view taken through the treatment chamber catheter 10 of Fig. 1 in the direction of the arrows at line 6-6. The distally extending first lumen 18 no longer includes the inflation lumen 40, terminated at the opening 50 to the distal expandable sealing member 26. The guide wire 30 is shown inside the distally extending first lumen 18.

Alternative Embodiments

An alternative embodiment of the treatment chamber catheter 10 of Fig. 1 uses the distal expandable sealing member 26 only. The proximal expandable sealing member 24 is not present. The distal expandable sealing member 26 forms a fluid seal with the walls of the biological conduit and will prevent an escape, in the distal direction, from the treatment chamber 34 of any excised tissue. But the treatment chamber 34 will not be sealed from the blood flow proximally.

In another alternative embodiment, the treatment chamber catheter 10 of Fig. 1 has no provision for natural perfusion of a biological fluid. Thus the distally extending first lumen 18 does not include openings 36 and 38 for perfusion. The distally extending first lumen 18 serves to support the distal expandable sealing member 26 and the distal atraumatic termination 32 only. Additional alternative embodiments of the present invention will now be described with respect to Figs. 7 through 10. Fig. 7 is a cross-sectional view taken through an alternative embodiment of the treatment chamber catheter 10, and corresponds to a cross-section taken in the direction of the arrows at line 2- 2 of Fig. 1. Fig. 8 corresponds to a cross-section taken in the direction of the arrows at line 3-3 of Fig. 1. Fig. 9 to a cross-section taken in the direction of the arrows at line 4-4 of Fig. 1 , and Fig. 10 corresponds to a cross-section taken in the direction of the arrows at line 5-5 of Fig. 1.

The next alternative embodiment will be discussed with respect to Figs. 7 through 10 and has a provision for independent inflation of the proximal and the distal expandable sealing members 24, 26. Fig. 7 shows that an outer wall 73 of a distally extending first lumen 72 encloses independent inflation lumen 52, 54, one for each of the expandable sealing members 24, 26. In Fig. 8 an opening 56 is shown connecting lumen 52 with the interior of the proximal expandable sealing member 24. Fig. 9 illustrates that lumen 52 terminates distally to the opening 56. Lumen 54 includes no opening to the interior of the proximal sealing member 24, as shown in Fig. 8, and extends distally to an opening 58 into the interior of the distal sealing member 26, as illustrated in Fig. 10. Lumen 54 terminates distally to the opening 58.

In another alternative embodiment, Figs. 7 and 8 illustrate that two additional lumina 60, 62 have been created within the space originally occupied solely by the second lumen 20 of Fig. 2. Lumina 60 and 62 open into the treatment chamber 34, one of the lumina providing for infusion and the other lumen providing for aspiration of flushing or other fluids and debris within the treatment chamber.

Fig. 11 illustrates an alternative embodiment which includes forced or assisted perfusion in which a mechanical pump is used to maintain or increase a rate of blood flow through the distally extending first lumen 18 and the perfusion openings 36, 38. Fig. 11 shows a portion of the distally extending first lumen 18 of Fig. 1. The distally extending first lumen 18 includes an in-line fluid pumping device 64 which is operated proximally by a rotating control member 66. Rotation of the control member 66 forces a fluid flow within the distally extending first lumen 18 in the direction of the arrows 68 and 70. The rotating control member 66 extends proximally to the proximal end 14 of the multiple lumen catheter member 12. The in-line fluid pumping device 64 has first and second ends and is adapted to mate compatibly with the distally extending first lumen 18. Fig. 12 is a cross-sectional view taken through an alternative embodiment of a multiple lumen catheter member 78 in the direction of the arrows at a point corresponding to the line 2-2 of Fig. 1. The embodiment provides for a forced perfusion, as defined above, and has first and second perfusion lumina, 74 and 76. The first perfusion lumen includes openings 36 (Fig. 1) proximal to the proximal expandable sealing member 24. The second perfusion lumen includes openings 38 (Fig. 1) distal to the distal expandable sealing member 26. Both perfusion lumina 74, 76 are terminated distally of their respective openings 36, 38. A conduit's biological fluid enters the proximal openings 36 and moves proximally through the first perfusion lumen toward the proximal end 14. A perfusion pump (not shown) is connected to the proximal end 14 to receive the fluid moving proximally and to transfer the fluid into the second perfusion lumen. The fluid then moves distally through the second perfusion lumen and reenters the biological conduit through the distal openings 38.

A final alternative embodiment is illustrated in Figs. 13 through 15. The embodiment eliminates the proximal expandable sealing member 24, and replaces the distal expandable sealing member 26 with a filtering member such as a fine meshed screen member 80.

Fig. 13 is a partial side view showing the treatment chamber 34 and a portion of the multiple lumen catheter member 12 and the distally extending first lumen 18. The screen member 80 has a conical shape, being of greater diameter proximally and being fitted closely to the outer surface 28 of the distally extending first lumen 18 distally of the treatment chamber 34.

An expandable ring member 82 is disposed circumferentially around a proximal end 83 of the screen member 80. A distal end 84 of the screen member 80 is attached to the outer surface 28. The expandable ring 82 is connected via inflation lumen 86 to the distally extending first lumen 18. An alternative embodiment of the screen member 80 includes use of a push wire (not shown) extending distally through the distally extending first lumen 18 and then through an opening, then radially to the proximal end 83 (Fig. 13) of the screen member 80. The push wire encircles the proximal end 83 so that when the wire is advanced distally, it enlarges the proximal end 83 in the manner shown in Figs. 13, 14. When the wire is moved proximally, it causes the screen member 80 to retract to a position shown in Fig. 15. Alternatively, an umbrella type mechanism (not shown) is used to open and close the screen member 80. The distally extending first lumen 18 is terminated distally at an atraumatic lumen termination 32. A guide wire 30 is shown extending distally through the distally extending first lumen 18, and passing through the atraumatic lumen termination 32. The expandable ring 82 is inflated by infusion of a liquid through the distally extending first lumen 18 and the inflation lumen 86.

The alternative embodiment of Fig. 13 is shown in a partial perspective view in Fig. 14. The screen member 80 is shown in an inflated or extended position in which the expandable ring 82 will form a seal with the walls of a biological conduit. When a catheter-type cutting or abrading device is inserted into the treatment chamber 34, excised tissue is prevented from escaping the treatment chamber 34 by the screen member 80 and by the seal formed by the expandable ring 82. The direction of the natural biological fluid flow is indicated by the arrow 88 and is toward the distal end 16 (Fig. 1). The inflation lumen 86 and its connections to both the inflation ring 82 and the distally extending first lumen 18 are more clearly seen in Fig. 14. The inflation ring 82 is seen not to be connected or supported in any manner by the distally extending first lumen 18. Fig. 15 is a partial perspective view of the alternative embodiment of

Figs. 13 and 14, and illustrates the screen member 80 in a deflated or retracted position. The screen member 80 is shown folded closely against the outer surface 28. The expandable ring 82 is shown in a deflated condition against the surface 28. The screen member 80 is placed in the retracted position in order that the treatment chamber catheter 10 can be inserted, manipulated, or removed from a biological conduit.

While the foregoing detailed description has described several embodiments of the treatment chamber catheter device 10 in accordance with this invention, it is to be understood that the above description is illustrative only and not limiting of the disclosed invention. It will be appreciated that the specific arrangement of the lumina relative to one another can differ from the examples shown in the accompanying figures and remain within the scope and spirit of this invention. Thus the invention is to be limited only by the claims as set forth below.

Claims

Claims:
1. A treatment chamber catheter for insertion into a biological conduit, the catheter comprising: a catheter member including multiple lumina and having proximal and distal ends; an expandable sealing member for sealing off fluid flow between the proximal and distal ends within the biological conduit defining a treatment chamber between the proximal and distal ends, the catheter member having a lumen for accessing the treatment chamber and for removing fluid and biological debris from the treatment chamber, whereby, an accessible, sealed treatment chamber is provided which retains loosened biological material for removal through the second lumen.
2. A treatment chamber catheter as set forth in Claim 1 , wherein the expandable sealing member includes first and second expandable members, one expandable member being distal to, the other proximal to the treatment chamber.
3. A treatment chamber catheter as set forth in Claim 2, wherein the catheter member includes an expansion lumen communicating with the expandable members, whereby a fluid may be introduced through the expansion lumen to expand the members and may be withdrawn to contract the members.
4. A treatment chamber catheter as set forth in Claim 2, wherein a separate expansion lumen is provided for each expandable member.
5. A treatment chamber catheter as set forth in Claim 2, further including perfusion means for allowing biological fluid within the conduit to bypass the sealed treatment chamber, the perfusion means having first and second openings being interconnected by another lumen, the first opening being proximal to a proximal expandable member, and the second opening being distal to a distal expandable member.
6. A treatment chamber catheter as set forth in Claim 5, wherein the perfusion means includes means for forced perfusion.
7. A treatment chamber catheter as set forth in Claim 1 , further including an infusion lumen having an opening into the treatment chamber, whereby a flushing solution or medication can be introduced through the infusion lumen into the treatment chamber.
8. A treatment chamber catheter as set forth in Claim 1 , further including guide means for guiding the catheter member to the desired location within the biological conduit.
9. A treatment chamber catheter for insertion into a biological conduit, the catheter comprising: a catheter member including multiple lumina and having proximal and distal ends; expandable sealing means for creating a barrier to fluid flow within the biological conduit, the expandable sealing means being located near the distal end of the catheter and communicating with a first lumen for expansion and contraction by a fluid transfer through the first lumen, the first lumen extending distally to the expandable sealing means; a treatment chamber defined by a second lumen having an opening proximal to the expandable sealing means, the opening providing access from the second lumen to the biological conduit; and guiding means for guiding the catheter tube to a desired location, whereby a catheter treatment chamber is created proximal to a conduit fluid barrier.
10. A treatment chamber catheter as set forth in Claim 9 further including second expandable sealing means proximal to the treatment chamber.
11. A treatment chamber catheter as set forth in Claim 10, wherein both sealing means communicate with the first lumen for expansion and contraction by fluid transfer.
12. A treatment chamber catheter as set forth in Claim 10, wherein the second expandable sealing means communicates with a third lumen for expansion and contraction by fluid transfer, the third lumen terminating distally to the expandable second sealing means.
13. A treatment chamber catheter as set forth in Claim 9 further including perfusion means defining a perfusion lumen for allowing a controlled flow of conduit fluid through the lumen to bypass the expandable sealing means.
14. A treatment chamber catheter as set forth in Claim 13 wherein the perfusion lumen includes pumping means for producing a forced, controlled bypass fluid flow.
15. A treatment chamber catheter as set forth in Claim 9 further including forced perfusion means for producing a forced, controlled bypass fluid flow, the perfusion means defining a fourth lumen communicating with an opening distal to the expandable sealing means and a fifth lumen communicating with an opening proximal to the expandable sealing means, and having pumping means connecting the proximal ends of the fourth and fifth lumina for receiving a conduit fluid from one of the lumina and pumping the fluid into the other lumen, whereby a forced, controlled bypass fluid flow is achieved.
16. A treatment chamber catheter as set forth in Claim 12 further including perfusion means defining one of the lumen and having a first opening distal to the distal expandable sealing means and a second opening proximal to the proximal expandable sealing means for providing a conduit fluid bypass around the treatment chamber, the defined lumen terminating distally to the first opening.
17. A treatment chamber catheter for insertion into a biological conduit, the treatment chamber catheter comprising: a catheter member having a proximal end and a distal end, the catheter member including a first lumen having an opening proximal to the distal end, and having a second lumen extending from the proximal end to the distal end of the catheter member, the catheter member having an outer surface; guide wire means for guiding the treatment chamber catheter within the biological conduit; a filtering member being disposed externally and circumferentially near the distal end of the extending second lumen, the filtering member having a distal end and a proximal end, the distal end being adapted to closely fit the outer surface, the proximal end of the filtering member being adapted to expand to an approximately circular shape for making contact with a conduit wall; means for expanding the proximal end of the filtering member, whereby when the treatment chamber catheter is located within a biological conduit and the filtering member is expanded until its proximal end is in contact with the inner walls of the biological conduit, a treatment chamber is created having a distally located porous barrier which allows the conduit's natural biological fluids to pass while preventing escape from the treatment chamber of excised biological tissue.
18. The treatment chamber catheter of claim 17 wherein the means for expanding the proximal end of the filtering member includes an inflatable member being disposed circumferentially at the proximal end of the filtering member, and further includes an inflation lumen for communication between the inflatable member and the second lumen.
19. The treatment chamber catheter of claim 17 wherein the filtering member comprises a fine meshed screen.
20. The treatment chamber catheter of claim 18 wherein the inflatable member forms a seal with the inner wall of the biological conduit when the member is inflated.
PCT/US1994/009262 1993-08-18 1994-08-18 Treatment chamber catheter WO1995005209A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10921593 true 1993-08-18 1993-08-18
US08/109,215 1993-08-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU7567394A AU7567394A (en) 1993-08-18 1994-08-18 Treatment chamber catheter

Publications (1)

Publication Number Publication Date
WO1995005209A1 true true WO1995005209A1 (en) 1995-02-23

Family

ID=22326426

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/009262 WO1995005209A1 (en) 1993-08-18 1994-08-18 Treatment chamber catheter

Country Status (1)

Country Link
WO (1) WO1995005209A1 (en)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0852509A1 (en) * 1995-09-27 1998-07-15 Interventional Innovations Corporation Thrombosis treatment
EP0872257A2 (en) * 1997-04-15 1998-10-21 Schneider ( Europe) GmbH Catheter
WO1998051237A1 (en) * 1997-05-16 1998-11-19 Jonathan Gertler Catheter-filter set having a compliant seal
EP0935978A1 (en) * 1998-02-16 1999-08-18 Medicorp S.A. Angioplasty and stent delivery catheter
US5954745A (en) * 1997-05-16 1999-09-21 Gertler; Jonathan Catheter-filter set having a compliant seal
WO1999058174A3 (en) * 1998-05-08 2000-01-27 Cardeon Corp Circulatory support system and method of use for isolated segmental perfusion
US6059809A (en) * 1998-02-16 2000-05-09 Medicorp, S.A. Protective angioplasty device
WO2000032266A1 (en) * 1998-12-03 2000-06-08 Benedini, Roberto Endovascular system for the treatment of stenoses of the carotid and catheter for this system
FR2803532A1 (en) * 2000-01-11 2001-07-13 Henri Julien Ronsse Double balloon catheter for revascularisation of arteries has perforated sheath with haemostatic valve controlling two occlusion balloons
EP1316292A1 (en) * 2001-11-29 2003-06-04 Medtronic Ave, Inc. Apparatus for temporary intraluminal protection
EP1374930A1 (en) * 1998-05-08 2004-01-02 Cardeon Corporation Circulatory support system for isolated segmental perfusion
WO2004024031A1 (en) * 2002-09-11 2004-03-25 Advanced Cardiovascular Systems, Inc. Aspiration catheter
EP2110151A1 (en) 2008-04-16 2009-10-21 Edward Diethrich Double balloon occlusion device
EP2236171A3 (en) * 2003-05-09 2010-10-27 Delcath Systems, Inc. Apparatus For Treating Glandular Diseases And Malignancies
US7938820B2 (en) 2005-08-18 2011-05-10 Lumen Biomedical, Inc. Thrombectomy catheter
EP2326381A2 (en) * 2008-08-26 2011-06-01 Silicon Valley Medical Instruments, Inc. Distal section for monorail catheter
EP2334367A1 (en) * 2008-08-21 2011-06-22 Cornell University Method and apparatus for accessing the wall of a vascular structure or other body lumen while simultaneously providing zone isolation and fluid bypass capability
WO2011079111A1 (en) 2009-12-21 2011-06-30 Acist Medical Systems, Inc. Thrombus removal device and system
US7976516B2 (en) 2004-06-25 2011-07-12 Lumen Biomedical, Inc. Medical device having mechanically interlocked segments
US7988705B2 (en) 2004-03-06 2011-08-02 Lumen Biomedical, Inc. Steerable device having a corewire within a tube and combination with a functional medical component
US8021351B2 (en) 2005-08-18 2011-09-20 Medtronic Vascular, Inc. Tracking aspiration catheter
US8092483B2 (en) 2004-03-06 2012-01-10 Medtronic, Inc. Steerable device having a corewire within a tube and combination with a functional medical component
US8409237B2 (en) 2004-05-27 2013-04-02 Medtronic, Inc. Emboli filter export system
US8603064B2 (en) 2008-09-22 2013-12-10 Covidien Lp Double balloon catheter and methods for homogeneous drug delivery using the same
US8858490B2 (en) 2007-07-18 2014-10-14 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US8870805B2 (en) 2003-11-21 2014-10-28 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
WO2014182699A1 (en) * 2013-05-06 2014-11-13 The Johns Hopkins University Inferior vena cava (ivc) shunt, double-balloon catheter for occlusion as a surgical tool
US8911497B2 (en) 2009-04-09 2014-12-16 DePuy Synthes Products, LLC Minimally invasive spine augmentation and stabilization system and method
US8932326B2 (en) 2008-06-10 2015-01-13 Cornell University Method and apparatus for repairing vascular abnormalities and/or other body lumen abnormalities using an endoluminal approach and a flowable forming material
US9011364B2 (en) 2007-07-18 2015-04-21 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US9023070B2 (en) 2010-05-13 2015-05-05 Rex Medical, L.P. Rotational thrombectomy wire coupler
US9114019B2 (en) 2007-11-16 2015-08-25 DePuy Synthes Products, Inc. Porous containment device and associated method for stabilization of vertebral compression fractures
US9126018B1 (en) 2014-09-04 2015-09-08 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9138527B2 (en) 2009-06-03 2015-09-22 Silk Road Medical, Inc. System and methods for controlling retrograde carotid arterial blood flow
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US9282992B2 (en) 2010-05-13 2016-03-15 Rex Medical, L.P. Rotational thrombectomy wire
EP2614765B1 (en) * 2004-02-09 2016-10-19 Smart Medical Systems Ltd. Endoscope assembly
US9532792B2 (en) 2008-07-14 2017-01-03 Medtronic, Inc. Aspiration catheters for thrombus removal
US9539041B2 (en) 2013-09-12 2017-01-10 DePuy Synthes Products, Inc. Minimally invasive biomaterial injection system
US9597101B2 (en) 2010-04-13 2017-03-21 Mivi Neuroscience, Inc. Embolectomy devices and methods for treatment of acute ischemic stroke condition
US9669191B2 (en) 2008-02-05 2017-06-06 Silk Road Medical, Inc. Interventional catheter system and methods
US9700346B2 (en) 2010-05-13 2017-07-11 Rex Medical, L.P. Rotational thrombectomy wire
US9795406B2 (en) 2010-05-13 2017-10-24 Rex Medical, L.P. Rotational thrombectomy wire
US9820761B2 (en) 2014-03-21 2017-11-21 Route 92 Medical, Inc. Rapid aspiration thrombectomy system and method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4723549A (en) * 1986-09-18 1988-02-09 Wholey Mark H Method and apparatus for dilating blood vessels
US5053008A (en) * 1990-11-21 1991-10-01 Sandeep Bajaj Intracardiac catheter
US5152277A (en) * 1987-07-23 1992-10-06 Terumo Kabushiki Kaisha Catheter tube
US5158540A (en) * 1985-12-19 1992-10-27 Leocor, Inc. Perfusion catheter

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158540A (en) * 1985-12-19 1992-10-27 Leocor, Inc. Perfusion catheter
US4723549A (en) * 1986-09-18 1988-02-09 Wholey Mark H Method and apparatus for dilating blood vessels
US5152277A (en) * 1987-07-23 1992-10-06 Terumo Kabushiki Kaisha Catheter tube
US5053008A (en) * 1990-11-21 1991-10-01 Sandeep Bajaj Intracardiac catheter

Cited By (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0852509A4 (en) * 1995-09-27 2000-01-05 Interventional Innovations Cor Thrombosis treatment
EP0852509A1 (en) * 1995-09-27 1998-07-15 Interventional Innovations Corporation Thrombosis treatment
EP0872257A3 (en) * 1997-04-15 1999-12-01 Schneider ( Europe) GmbH Catheter
EP0872257A2 (en) * 1997-04-15 1998-10-21 Schneider ( Europe) GmbH Catheter
WO1998051237A1 (en) * 1997-05-16 1998-11-19 Jonathan Gertler Catheter-filter set having a compliant seal
US5954745A (en) * 1997-05-16 1999-09-21 Gertler; Jonathan Catheter-filter set having a compliant seal
WO1999040964A1 (en) * 1998-02-16 1999-08-19 Medicorp S.A. Angioplasty and stent delivery catheter
US6059809A (en) * 1998-02-16 2000-05-09 Medicorp, S.A. Protective angioplasty device
EP0935978A1 (en) * 1998-02-16 1999-08-18 Medicorp S.A. Angioplasty and stent delivery catheter
WO1999058174A3 (en) * 1998-05-08 2000-01-27 Cardeon Corp Circulatory support system and method of use for isolated segmental perfusion
EP1374930A1 (en) * 1998-05-08 2004-01-02 Cardeon Corporation Circulatory support system for isolated segmental perfusion
EP1611918A2 (en) * 1998-12-03 2006-01-04 Benedini, Roberto Endovascular system for the treatment of stenoses of the carotid and catheter for this system
US7384412B2 (en) 1998-12-03 2008-06-10 Invatec S.R.L. Endovascular system for the treatment of stenoses of the carotid and catheter for this system
US6595953B1 (en) 1998-12-03 2003-07-22 Gioacchino Coppi Endovascular system for the treatment of stenoses of the carotid and catheter for this system
WO2000032266A1 (en) * 1998-12-03 2000-06-08 Benedini, Roberto Endovascular system for the treatment of stenoses of the carotid and catheter for this system
EP1611918A3 (en) * 1998-12-03 2006-06-07 Invatec S.r.l Endovascular system for the treatment of stenoses of the carotid and catheter for this system
US7083594B2 (en) 1998-12-03 2006-08-01 Invatec S.R.L. Endovascular system for the treatment of stenoses of the carotid and catheter for this system
FR2803532A1 (en) * 2000-01-11 2001-07-13 Henri Julien Ronsse Double balloon catheter for revascularisation of arteries has perforated sheath with haemostatic valve controlling two occlusion balloons
EP1316292A1 (en) * 2001-11-29 2003-06-04 Medtronic Ave, Inc. Apparatus for temporary intraluminal protection
WO2004024031A1 (en) * 2002-09-11 2004-03-25 Advanced Cardiovascular Systems, Inc. Aspiration catheter
EP2236171A3 (en) * 2003-05-09 2010-10-27 Delcath Systems, Inc. Apparatus For Treating Glandular Diseases And Malignancies
US9662118B2 (en) 2003-11-21 2017-05-30 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US9526504B2 (en) 2003-11-21 2016-12-27 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
US8870805B2 (en) 2003-11-21 2014-10-28 Silk Road Medical, Inc. Method and apparatus for treating a carotid artery
EP2614765B1 (en) * 2004-02-09 2016-10-19 Smart Medical Systems Ltd. Endoscope assembly
US8092483B2 (en) 2004-03-06 2012-01-10 Medtronic, Inc. Steerable device having a corewire within a tube and combination with a functional medical component
US7988705B2 (en) 2004-03-06 2011-08-02 Lumen Biomedical, Inc. Steerable device having a corewire within a tube and combination with a functional medical component
US8409237B2 (en) 2004-05-27 2013-04-02 Medtronic, Inc. Emboli filter export system
US7976516B2 (en) 2004-06-25 2011-07-12 Lumen Biomedical, Inc. Medical device having mechanically interlocked segments
US7938820B2 (en) 2005-08-18 2011-05-10 Lumen Biomedical, Inc. Thrombectomy catheter
US8021351B2 (en) 2005-08-18 2011-09-20 Medtronic Vascular, Inc. Tracking aspiration catheter
US8758325B2 (en) 2005-08-18 2014-06-24 Medtronic, Inc. Rapid exchange catheter
US9833555B2 (en) 2007-07-18 2017-12-05 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US9655755B2 (en) 2007-07-18 2017-05-23 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9011364B2 (en) 2007-07-18 2015-04-21 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US8858490B2 (en) 2007-07-18 2014-10-14 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9789242B2 (en) 2007-07-18 2017-10-17 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US9259215B2 (en) 2007-07-18 2016-02-16 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US10085864B2 (en) 2007-07-18 2018-10-02 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9114019B2 (en) 2007-11-16 2015-08-25 DePuy Synthes Products, Inc. Porous containment device and associated method for stabilization of vertebral compression fractures
US9669191B2 (en) 2008-02-05 2017-06-06 Silk Road Medical, Inc. Interventional catheter system and methods
EP2110151A1 (en) 2008-04-16 2009-10-21 Edward Diethrich Double balloon occlusion device
US8932326B2 (en) 2008-06-10 2015-01-13 Cornell University Method and apparatus for repairing vascular abnormalities and/or other body lumen abnormalities using an endoluminal approach and a flowable forming material
US9532792B2 (en) 2008-07-14 2017-01-03 Medtronic, Inc. Aspiration catheters for thrombus removal
US10058339B2 (en) 2008-07-14 2018-08-28 Medtronic, Inc. Aspiration catheters for thrombus removal
US9662129B2 (en) 2008-07-14 2017-05-30 Medtronic Inc. Aspiration catheters for thrombus removal
EP2334367A4 (en) * 2008-08-21 2012-01-04 Univ Cornell Method and apparatus for accessing the wall of a vascular structure or other body lumen while simultaneously providing zone isolation and fluid bypass capability
EP2334367A1 (en) * 2008-08-21 2011-06-22 Cornell University Method and apparatus for accessing the wall of a vascular structure or other body lumen while simultaneously providing zone isolation and fluid bypass capability
US9295818B2 (en) 2008-08-21 2016-03-29 Cornell University Method and apparatus for accessing the wall of a vascular structure or other body lumen while simultaneously providing zone isolation and fluid bypass capability
EP2326381A2 (en) * 2008-08-26 2011-06-01 Silicon Valley Medical Instruments, Inc. Distal section for monorail catheter
EP2326381A4 (en) * 2008-08-26 2011-09-21 Silicon Valley Medical Instr Inc Distal section for monorail catheter
US8603064B2 (en) 2008-09-22 2013-12-10 Covidien Lp Double balloon catheter and methods for homogeneous drug delivery using the same
US8911497B2 (en) 2009-04-09 2014-12-16 DePuy Synthes Products, LLC Minimally invasive spine augmentation and stabilization system and method
US9138527B2 (en) 2009-06-03 2015-09-22 Silk Road Medical, Inc. System and methods for controlling retrograde carotid arterial blood flow
WO2011079111A1 (en) 2009-12-21 2011-06-30 Acist Medical Systems, Inc. Thrombus removal device and system
EP2515991A4 (en) * 2009-12-21 2016-03-30 Acist Medical Sys Inc Thrombus removal device and system
US9597101B2 (en) 2010-04-13 2017-03-21 Mivi Neuroscience, Inc. Embolectomy devices and methods for treatment of acute ischemic stroke condition
US10064645B2 (en) 2010-05-13 2018-09-04 Rex Medical, L.P. Rotational thrombectomy wire
US9282992B2 (en) 2010-05-13 2016-03-15 Rex Medical, L.P. Rotational thrombectomy wire
US9700346B2 (en) 2010-05-13 2017-07-11 Rex Medical, L.P. Rotational thrombectomy wire
US9795406B2 (en) 2010-05-13 2017-10-24 Rex Medical, L.P. Rotational thrombectomy wire
US9023070B2 (en) 2010-05-13 2015-05-05 Rex Medical, L.P. Rotational thrombectomy wire coupler
US10045785B2 (en) 2013-05-06 2018-08-14 The Johns Hopkins University Inferior vena cava (IVC) shunt, double-balloon catheter for occlusion as a surgical tool
WO2014182699A1 (en) * 2013-05-06 2014-11-13 The Johns Hopkins University Inferior vena cava (ivc) shunt, double-balloon catheter for occlusion as a surgical tool
US9539041B2 (en) 2013-09-12 2017-01-10 DePuy Synthes Products, Inc. Minimally invasive biomaterial injection system
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US9561345B2 (en) 2013-12-23 2017-02-07 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US9492637B2 (en) 2013-12-23 2016-11-15 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US9861783B2 (en) 2013-12-23 2018-01-09 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US9820761B2 (en) 2014-03-21 2017-11-21 Route 92 Medical, Inc. Rapid aspiration thrombectomy system and method
US10039906B2 (en) 2014-09-04 2018-08-07 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9241699B1 (en) 2014-09-04 2016-01-26 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9662480B2 (en) 2014-09-04 2017-05-30 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9399118B2 (en) 2014-09-04 2016-07-26 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9126018B1 (en) 2014-09-04 2015-09-08 Silk Road Medical, Inc. Methods and devices for transcarotid access

Similar Documents

Publication Publication Date Title
US6761727B1 (en) Filter assembly
US5320634A (en) Balloon catheter with seated cutting edges
US6929652B1 (en) Delivery and recovery systems having steerability and rapid exchange operating modes for embolic protection systems
US5776140A (en) Stent delivery system
US6905490B2 (en) Apparatus and methods for reducing embolization during treatment of carotid artery disease
US5370617A (en) Blood perfusion balloon catheter
US4748984A (en) Catheter assembly and method of performing coronary angiography and angioplasty
US7422579B2 (en) Emboli protection devices and related methods of use
US6013085A (en) Method for treating stenosis of the carotid artery
US5370653A (en) Thrombectomy method and apparatus
US6527789B1 (en) Stent delivery system
US4886061A (en) Expandable pullback atherectomy catheter system
US5078685A (en) Catheter with exterior tunnel member
US4867156A (en) Percutaneous axial atheroectomy catheter assembly and method of using the same
US5681336A (en) Therapeutic device for treating vien graft lesions
US6443926B1 (en) Embolic protection device having expandable trap
US6706033B1 (en) Modular access port for device delivery
US7507246B2 (en) Rotational thrombectomy device
US5295493A (en) Anatomical guide wire
US6206868B1 (en) Protective device and method against embolization during treatment of carotid artery disease
US20060253145A1 (en) Multi-functional thrombectomy device
US4950277A (en) Atherectomy cutting device with eccentric wire and method
US4898575A (en) Guide wire following tunneling catheter system and method for transluminal arterial atherectomy
US5908435A (en) Expandable lumen device and method of use
US6908474B2 (en) Apparatus and methods for reducing embolization during treatment of carotid artery disease

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: CA